Brown University
Back to Results

Private Equity Rollups of Physician Practices: Evidence from Gastroenterology

Description

Abstract:
The competitive effects of emerging “platform and add-on” consolidation strategies, which often escape regulatory scrutiny, remain understudied. We examine whether private equity (PE) rollups affect prices through changes in local market power, PE-specific mechanisms, or both, using a difference-in-differences design and novel hand-compiled data on platform and add-on acquisitions by 7 PE firms in gastroenterology. We find that both initial platform and add-on acquisitions increase prices, with add-on acquisitions generating larger effects. Within-market add-ons, which increase acquiring firms' market share by approximately 14 percentage points, raise prices by 10%. Cross-market acquisitions in geographically distinct markets, which by construction leave local market concentration unchanged, raise prices by 3%. Cross-market price increases reflect the diffusion of platform pricing strategies, whereby acquired practices rapidly converge to the negotiated rates established by their PE-backed platforms. We find no evidence of changes to patient outcomes or patient selection. Overall, our findings suggest that regulatory frameworks focused exclusively on local market concentration may understate the cumulative competitive effects of rollup acquisitions, with implications for antitrust enforcement and the ongoing policy debate over whether PE-specific regulatory treatment is warranted.

Access Conditions

Use and Reproduction
All rights reserved
Rights
In Copyright
Restrictions on Use
All Rights Reserved

Citation

Yashaswini Singh, and Christopher M. Whaley, "Private Equity Rollups of Physician Practices: Evidence from Gastroenterology" (2026). Center for Advancing Health Policy through Research (CAHPR) Digital Collection. Brown Digital Repository. Brown University Library. https://doi.org/10.26300/gxsx-7y24

Relations

Collection: